2022 Real Estate Top 150 ranking: 15
Despite a surge in investor interest, UK life sciences remains a very niche real estate sub-sector. For the investment proposition to stack-up, the underlying occupier fundamentals must repay the risks associated with investing in an emerging sector.
You are not logged in, Sign in or register to request access.
Please note: If you had prior access to this content you may need to sign in again.
Non-asset management investment service providers are able to purchase a subscription for access to premium content such as:
Get access to premium content subscribe today